Caffeine inhibits hepatic-microsomal activation of some dietary genotoxins

Area of Science:

• Biochemistry
• Toxicology
• Pharmacology

Background:

• Heterocyclic aromatic amines (HAAs) are potent mutagens formed during cooking.
• Hepatic microsomes play a key role in metabolizing HAAs, influencing their mutagenicity.
• Understanding modulators of HAA metabolism is crucial for assessing their health risks.

Purpose of the Study:

• To investigate the effect of caffeine on the mutagenicity of specific HAAs (MeIQ, Trp-P-2, MeIQx).
• To elucidate the mechanism by which caffeine modifies HAA metabolism in hepatic microsomes.
• To determine if caffeine's effect is related to metabolic inhibition, mutagen uptake, or bacterial DNA repair.

Main Methods:

• Preparation of hepatic microsomal fractions from female BALB/c mice.
• Incubation of microsomes with MeIQ, Trp-P-2, and MeIQx in the presence and absence of caffeine.
• Assessment of mutagenicity using Salmonella typhimurium TA98 as the indicator organism.
• Analysis of caffeine's inhibitory effects on microsomal metabolism.

Main Results:

• Caffeine significantly inhibited the mutagenicity of MeIQ, Trp-P-2, and MeIQx.
• The inhibition was attributed to caffeine's effect on the microsomal metabolism of these HAAs.
• Evidence suggested caffeine did not alter the uptake of active mutagens or interact with bacterial DNA repair.
• Similar inhibition constants (Ki) for the three HAAs indicated a common metabolic inhibition site.

Conclusions:

• Caffeine acts as an inhibitor of hepatic microsomal metabolism for tested heterocyclic aromatic amines.
• The mechanism of inhibition involves blocking a common metabolic step rather than affecting mutagen uptake or DNA repair.
• These findings highlight caffeine's potential role in modulating the toxicological profiles of HAAs.